Ep. 124: CureLedger's Role in the New Era of Health Data Sharing with David Stefanich, Nina Kilbride, Dr. Suren Movsisyan

David Stefanich, Nina Kilbride, and Dr. Sarin Movsisyan from CureLedger join host Ray Dogum to discuss their upcoming token launch. The discussion centers on CureLedger, an initiative aimed at transforming the decentralized science (DeSci) landscape through blockchain and Web3 technologies. David speaks about Rymedi’s foundational software for Clemson University's COVID-19 testing and their evolution into CureLedger. Nina introduces her vast experience as a commercial litigation attorney and how AI and verifiable data ignited her interest in Web3. Suren emphasizes the importance of blockchain for multi-jurisdictional compliance and data security. The CureLedger team explores its unique Layer 1 protocol, emphasis on data sovereignty, and the creation of a verifiable health data marketplace. They also touch on tokenomics, community incentives, and upcoming events like the ETH Denver announcement.

🎙️Health Unchained is the Top #15 of 100 Healthcare Technology Podcasts on the web - Check us out on Feedspot

Timestamps

• 00:00 Intro
• 01:59 David Stefanich's Journey and CureLedger
• 03:18 Nina Kilbride's Background
• 06:09 Blockchain's Impact on Healthcare
• 08:33 Challenges and Solutions in Data Sharing
• 10:34 CureLedger's Unique Architecture
• 22:27 Patient Data Sovereignty and Future Prospects
• 32:42 Data Marts and Regulatory Compliance
• 34:41 Tokenomics of Cure Ledger
• 37:31 Target Communities and Use Cases
• 40:49 Smart Contracts and Data Consent
• 43:15 Challenges and Future Plans
• 58:10 Follow Cure Ledger's Journey

Guests LinkedIn Profiles

• David Stefanich
• Nina Kilbride
• Dr. Suren Movsisyan

Mentioned Resources

• CureLedger website
• CureLedger Whitepaper
• CureLedger LinkedIn
• CureLedger Telegram Channel
• Ep. 73: Multi-party Trust with Rymedi - David Stefanich and Dr. Jason Cross
• Partnering with Good Pharma (Ep. 100 with Savva Kerdemelidis)

Health Unchained Links

• Supercast – Sign up to access premium content
• Website
• Telegram
• LinkedIn
• X